ANIP
Healthcare Drug Manufacturers - Specialty & GenericANI Pharmaceuticals, Inc.
$72.18
-0.93 -1.27% today
Price History
Not enough data
Key Stats
Market Cap
1.66B
Avg Volume
368,271
P/E (TTM)
15.73
EPS
$4.59
52W High
$97.00
52W Low
$69.58
Div. Yield
0.0%
Analyst Ratings
Buy3
Str Buy
4
Buy
2
Hold
0
Sell
0
Str Sell
Valuation
Forward P/E
6.94
P/B Ratio
2.59
P/S Ratio
1.69
EV/EBITDA
8.58
EV/Revenue
1.84
PEG Ratio
1.79
Margins
Gross Margin 60.4%
Operating Margin 15.0%
Net Margin 11.1%
EBITDA Margin 21.4%
Growth & Returns
Revenue Growth (YoY)
25.9%
Earnings Growth (YoY)
191.1%
Earnings Growth (QoQ)
189.1%
Return on Equity
20.5%
Return on Assets
5.4%
Liquidity & Leverage
Current Ratio
2.91
Quick Ratio
2.30
Debt / Equity
1.05
Total Cash
376.96M
Total Debt
626.03M
About
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
www.anipharmaceuticals.com